Dual surface protection coating for drug delivery balloon catheters and stents

• US 6,656,156 B2
• Filed: 05/22/2002
• Issued: 12/02/2003
• Est. Priority Date: 02/03/1999
• Status: Expired due to Fees

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Scimed Life Systems Incorporated (Boston Scientific Corporation)
• Inventors: Wang, Lixiao, Yang, Dachuan, Stanslaski, Joel
• Primary Examiner(s): Casler, Brian L.
• Assistant Examiner(s): Han, Mark K
• Application Number:
  US10/154,186
• Publication Number:
  US 20020151844A1
• Time in Patent Office: 559 Days
• Field of Search: 604/103.02, 604/96.01, 604/103.05, 604/103.06, 604/103.08, 604/103.11, 604/103.12, 604/103.13, 604/103.14, 604/915, 604/890.1, 606/192, 606/194
• US Class Current: 604/103.02
• CPC Class Codes: A61F 2/0077 Special surfaces of prostheses, e.g. for improving ingrowth A61F2/30767 takes precedence
• CPC Class Codes: A61F 2/91 made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
• CPC Class Codes: A61F 2/915 with bands having a meander structure, adjacent bands being connected to each other
• CPC Class Codes: A61F 2/958 Inflatable balloons for placing stents or stent-grafts
• CPC Class Codes: A61F 2002/91541 Adjacent bands are arranged out of phase
• CPC Class Codes: A61F 2002/91558 connected peak to peak
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body
• CPC Class Codes: A61L 2300/416 Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
• CPC Class Codes: A61L 2300/608 having two or more layers
• CPC Class Codes: A61L 2420/08 Coatings comprising two or more layers
• CPC Class Codes: A61L 29/085 Macromolecular materials
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence
• CPC Class Codes: A61L 31/10 Macromolecular materials
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence

Abstract

The invention relates to a medical device, such as a stent or a balloon catheter that includes an expandable body portion which has an exterior surface that contacts a vessel wall during treatment. The medical device includes a first coating disposed over at least a portion of the exterior surface. The first coating includes a therapeutic substance that is intended for controlled release from the exterior surface. The medical device further includes a second coating overlaying at least a substantial portion of the first coating. The second coating includes a material that is generally impervious to elution of the therapeutic substance therethrough when the body portion is inserted into the vessel lumen. The material of the second coating is relatively inelastic so that the second coating fractures during expansion of the body portion to allow elution of the therapeutic substance through fissures formed in the second coating.

Claims

1. A catheter for drug delivery comprising:

a longitudinally extending shaft having a distal end and a proximal end, the shaft defining an inflation lumen;

a balloon member having an exterior surface disposed proximate the distal end of said shaft in fluid communication with said inflation lumen, said balloon member expandable from a first position, wherein said balloon member is sized for intravascular insertion, to a second position, wherein at least a portion of said exterior surface contacts a vessel wall;

a first coating disposed over at least a portion of said exterior surface of said balloon member, said first coating comprising a therapeutic substance; and

a second coating overlying at least a substantial portion of said first coating when said balloon member is in said first position, wherein said second coating comprises a relatively inelastic material so that said second coating fractures in response to expansion of said balloon member to said second position to allow elution of said therapeutic substance through fissures formed in said second coating.

2. The catheter of claim 1, wherein said therapeutic substance would elute from said exterior surface in response to fluid contact if said second coating were absent.

3. The catheter of claim 1, wherein said material of said second coating comprises a polymeric material selected from the group consisting of polylactic acid, polyglycolic acid, polyanhydrides, polyphosphazenes, poly(orthoesters) and mixtures and copolymers thereof.

4. The catheter of claim 1, wherein said therapeutic substance is selected from the group consisting of:

taxol, taxol derivatives, colchicine, vinblastine and epothilone.

5. The catheter of claim 1, wherein said therapeutic substance is elutable when contacted with water-containing fluids if said second coating were absent.